Javascript was detected to be disabled. Javascript is required for some functions on this website.

NEWS ARTICLE

New Publication in the Discussion Paper Series

«Cost Effectiveness Thresholds: Are They Helpful or Do They Mislead Policy-Makers? Initial Findings from an Integrative Review»:

Cost effectiveness thresholds (CETs) are used in many jurisdictions to inform health care resource allocation decisions and therefore access to medical interventions. In countries with strong utilitarian traditions, their use is frequently formalized and associated with reduced patient access to innovative medicines, in particular for rare diseases. The impact does however exceed these countries, as policy makers are looking for tools that offer help to effectively set limits to health care spending and increase the efficiency of health care resource use. The purpose of the present project has therefore been to analyze and critically appraise the use of CETs to inform HTAs, and to provide a comprehensive review of the underlying logic of cost effectiveness (CE), illustrating and explaining its loopholes and the resulting failures as a universally applicable instrument to guide health care resource allocation in an ethically defensible manner.

In the (completed) first phase of the project, the conceptual foundations have been developed, and the feasibility of the chosen method – an integrative review approach – has been demonstrated. Tangible interim results include a completed systematic literature search, the IV Working Paper No. 39/2026, summarizing key insights, an 8,000-word manuscript undergoing peer review for publication in a leading health policy journal, and an oral presentation to ISPOR Europe in Vienna/Austria, November 11, 2026.

Here we give insight in emerging findings by providing access to our IV Working Papper No. 39, titled «Cost Effectiveness Thresholds: Are They Helpful or Do They Mislead Policy-Makers? Initial Findings from an Integrative Review».